1,415 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Wednesday’s Close
MRK Merck & Company, Inc. $61.9 $166.53B Uptrend
Article Searches
Does the $4.7 Billion Talc Verdict Spell Trouble for J&J? http://www.zacks.com/commentary/172105/does-the-%2447-billion-talc-verdict-spell-trouble-for-jj?cid=CS-ZC--172105 Jul 16, 2018 - Does the $4.7 Billion Talc Verdict Spell Trouble for J&J?
Amgen Resubmits BLA to FDA for Osteoporosis Candidate Evenity http://www.zacks.com/stock/news/311525/amgen-resubmits-bla-to-fda-for-osteoporosis-candidate-evenity?cid=CS-ZC-FT-311525 Jul 13, 2018 - Amgen Inc. (AMGN) and its partner UCB announce the resubmission of the BLA to the FDA for Evenity to treat osteoporosis in postmenopausal women and in men at increased risk of fracture.
Your Daily Pharma Scoop: ResTORbio Progresses, Roche Closer To Review, AbbVie Falters https://seekingalpha.com/article/4187039-daily-pharma-scoop-restorbio-progresses-roche-closer-review-abbvie-falters?source=feed_sector_healthcare Jul 13, 2018 - ResTORbio reports Phase 2 positive data.FDA accepts Roche’s marketing application for review.AbbVie’s candidate fails in Phase 3 trial.
Will J&J's (JNJ) Pharma Segment Strength Drive Q2 Earnings? http://www.zacks.com/stock/news/311395/will-jjs-jnj-pharma-segment-strength-drive-q2-earnings?cid=CS-ZC-FT-311395 Jul 13, 2018 - The positive trend seen in J&J's (JNJ) pharma segment sales in the past three quarters is likely to continue in Q2
Pharma Stock Roundup: PFE to Split Into 3 Units, J&J to Pay $4.7B in Talc Lawsuit http://www.zacks.com/stock/news/311394/pharma-stock-roundup-pfe-to-split-into-3-units-jj-to-pay-%2447b-in-talc-lawsuit?cid=CS-ZC-FT-311394 Jul 13, 2018 - Pfizer (PFE) is re-organizing its business into three new units, effective 2019. A St Louis jury orders J&J (JNJ) to pay $4.69 billion in a lawsuit related to its talc-based products.
Dow 30 Stock Roundup: Boeing Q2 Commercial Deliveries Up Y/Y, Pfizer to Reorganize http://www.zacks.com/stock/news/311384/dow-30-stock-roundup-boeing-q2-commercial-deliveries-up-y-y-pfizer-to-reorganize?cid=CS-ZC-FT-311384 Jul 13, 2018 - The index enjoyed a strong week of gains, boosted by expectations of a strong second quarter earnings season.
Chesley Taft & Associates Llc Buys iShares Core S&P Small-Cap, Merck Inc, United ... http://www.gurufocus.com/news/707301/chesley-taft--associates-llc-buys-ishares-core-sp-smallcap-merck-inc-united-technologies-corp-sells-philip-morris-international-inc-comcast-corp-invesco-senior-loan Jul 12, 2018 - Chesley Taft & Associates Llc Buys iShares Core S&P Small-Cap, Merck Inc, United Technologies Corp, Sells Philip Morris International Inc, Comcast Corp, Invesco Senior Loan, Stocks: IJR,MRK,UTX,NVDA,C,FLOT,STZ,BNDX,MTN,OKE,CSX,DVMT,, release date:Jul 12, 2018
3 Things In Biotech, July 12: Immunotherapy Brawl, And A Creeper In The Weeds https://seekingalpha.com/article/4186733-3-things-biotech-july-12-immunotherapy-brawl-creeper-weeds?source=feed_all_articles Jul 12, 2018 - Bristol-Myers comes back swinging in colorectal cancer. Pembro not to be outshone today, attacks a different GI cancer. Asterias wants you to know that they're getting there in lung cancer.
Pfizer (PFE) to Reorganize Business Into Three New Units http://www.zacks.com/stock/news/311263/pfizer-pfe-to-reorganize-business-into-three-new-units?cid=CS-ZC-FT-311263 Jul 12, 2018 - Pfizer (PFE) is re-organizing its business into three business segments, effective 2019. It is separating its consumer healthcare business into a standalone unit.
J&J (JNJ) to Set Pharma Q2 Earnings in Motion: What's Up? http://www.zacks.com/stock/news/311228/jj-jnj-to-set-pharma-q2-earnings-in-motion-whats-up?cid=CS-ZC-FT-311228 Jul 12, 2018 - The positive trend seen in J&J's (JNJ) pharma segment sales in the past three quarters is likely to continue in Q2.

Pages: 123456...142

Page 1>

Related Companies

Name Exchange Price Mkt Cap
NVS Novartis AG NYSE $76.35 $177.96B
ABBV AbbVie Inc. NYSE $94.96 $150.69B
NVO Novo Nordisk A/S NYSE $48.84 $118.19B
PFE Pfizer, Inc. NYSE $37.21 $217.66B
ABT Abbott Laboratories NYSE $62.57 $109.7B
Sector: Health Care > Industry: Major Pharmaceuticals
DeepLinks for Merck & Company
MRK - Google Finance https://www.google.com/finance?q=MRK Industry related info and international coverage Summary News
MRK - Bloomberg http://www.bloomberg.com/research/stocks/snapshot/snapshot.asp?ticker=MRK Original news and commentary from Bloomberg Charts Financials with pensions Snapshot Earnings Transactions People Options